PARP inhibition modulates the tumor immune microenvironment in Brca1-deficient ovarian tumor.

被引：0
|
作者：
Ding, Liya [1 ]
Wang, Qiwei [1 ]
Kearns, Michael [1 ]
Jiang, Tao [1 ]
Konstantinopoulos, Panagiotis [1 ]
Matulonis, Ursula [1 ]
Zhao, Jean [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
CLINICAL CANCER RESEARCH | 2020年 / 26卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA17
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [41] Shaping Immune Responses in the Tumor Microenvironment of Ovarian Cancer
    Luo, Xin
    Xu, Jing
    Yu, Jianhua
    Yi, Ping
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [42] Elucidating the role of amphiregulin in the ovarian tumor immune microenvironment
    Ebott, Jasmine
    McAdams, Julia
    De La Cruz, Payton
    Kim, Chloe
    James, Nicole E.
    CANCER RESEARCH, 2024, 84 (05)
  • [43] Elucidating the role of amphiregulin in the ovarian tumor immune microenvironment
    Ebott, Jasmine
    McAdams, Julia
    Woodman, Morgan
    De La Cruz, Payton
    Ribeiro, Jennifer
    James, Nicole
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S292 - S292
  • [44] Spatial tumor immune microenvironment phenotypes in ovarian cancer
    Mateiou, Claudia
    Lokhande, Lavanya
    Diep, Lan Hoa
    Knulst, Mattis
    Carlsson, Elias
    Ek, Sara
    Sundfeldt, Karin
    Gerdtsson, Anna
    NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [45] The tumor immune microenvironment of germline BRCA1/2 and sporadic prostate cancer
    Trigos, Anna S.
    Pasam, Anupama
    Banks, Patricia Diana
    Wallace, Roslyn
    Keam, Simon P.
    Thorne, Heather
    Mitchell, Catherine
    Clouston, David
    Murphy, Declan G.
    Lawrentschuk, Nathan
    Bolton, Damien M.
    Moon, Daniel
    Castro, Elena
    Olmos, David
    Darcy, Phillip K.
    Haupt, Ygal
    Williams, Scott
    Goode, David L.
    Neeson, Paul J.
    Sandhu, Shahneen Kaur
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [46] Assessing difference in the tumor and immune microenvironment of BRCA1/2 mutated versus BRCA wild type high grade serous ovarian cancers
    Qian, Jing
    Roman, Lynda D.
    Rajpara, Seeta
    Neuman, Monica
    Khetan, Varun
    Craig, David W.
    Carlson, Joseph
    Carpten, John D.
    CANCER RESEARCH, 2023, 83 (07)
  • [47] DYNLL1 INHIBITS DNA END RESECTION IN BRCA1-DEFICIENT CELLS AND REGULATES PARP INHIBITOR SENSITIVITY
    He, Yizhou Joseph
    Meghani, Khyati
    Caron, Marie-Christine
    Yang, Chunyu
    Ronato, Daryl A.
    Bian, Jie
    Sharma, Anchal
    Miller, Jessica
    Joshi, Niraj
    Detappe, Alexandre
    Doench, John G.
    Legube, Gaelle
    Root, David E.
    D'Andrea, Alan D.
    Drane, Pascal
    De, Subhojyoti
    Konstantinopoulos, Panagiotis
    Masson, Jean-Yves
    Chowdhury, Dipanjan
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 90 - 90
  • [48] Characterization of a novel p53; BRCA1-deficient claudin-low mammary tumor cell line
    Dance-Barnes, Stephanie T.
    Evans, Ebone
    Steward, Shanderys
    He, Xiaping
    Usary, Jerry
    Perou, Charles
    CANCER RESEARCH, 2016, 76
  • [49] Targeting the ATR/CHK1 Axis with PARP Inhibition Results in Tumor Regression in BRCA-Mutant Ovarian Cancer Models
    Kim, Hyoung
    George, Erin
    Ragland, Ryan L.
    Rafail, Stavros
    Zhang, Rugang
    Krepler, Clemens
    Morgan, Mark A.
    Herlyn, Meenhard
    Brown, Eric J.
    Simpkins, Fiona
    CLINICAL CANCER RESEARCH, 2017, 23 (12) : 3097 - 3108
  • [50] Bacterial lipopolysaccharide modulates immune response in the colorectal tumor microenvironment
    Sulit, A. K.
    Daigneault, M.
    Allen-Vercoe, E.
    Silander, O. K.
    Hock, B.
    McKenzie, J.
    Pearson, J.
    Frizelle, F. A.
    Schmeier, S.
    Purcell, R.
    NPJ BIOFILMS AND MICROBIOMES, 2023, 9 (01)
12345